Navigation Links
Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference
Date:3/3/2011

THOUSAND OAKS, Calif., March 3, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) will present at the Cowen and Company 31st Annual Healthcare Conference on Tuesday, March 8, 2011 at the Boston Marriott Copley Place, Boston, Mass., beginning at 8:45 a.m. Eastern Time.  James Daly, Amgen's Senior Vice President of North American Commercial Operations, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors.

About AmgenAmgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.CONTACT: Amgen, Thousand OaksDavid Polk, 805-447-4613 (media)Arvind Sood, 805-447-1060 (investors)(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results
2. Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass
3. Amgen and Xencor Enter Option Deal to Co-Develop Xencors Novel Antibody for Autoimmune Diseases
4. Call for Applications: The Amgen Award for Science Teaching Excellence
5. Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits
6. Amgen to Provide Testimony at FDA Hearing on Biosimilars
7. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
8. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
9. Array BioPharma and Amgen Partner in Type 2 Diabetes
10. Amgen to Present at Lazard Capital Healthcare Conference
11. Amgen Announces Webcast of 2009 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... Corista, a ... and artificial intelligence Tuesday, July 25, during the Association of Pathology Chairs’ Jubilee ... Medicine. , Baras, Associate Director of Pathology Informatics, will present “The Digital ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... to make clinical trial sites and study participants truly unified. TrialKit, a native ... (FDA 21 CFR Part 11) research studies entirely on mobile devices. With TrialKit, ...
(Date:7/18/2017)... ... 18, 2017 , ... Genedata, a leading provider of advanced ... company, has implemented Genedata Biologics ™ to scale-up their bispecific antibody discovery ... Neurodegenerative Diseases. , The need to systematically evaluate large panels of multi-specific ...
(Date:7/18/2017)... ... July 18, 2017 , ... Allotrope ... released the first phase of the Allotrope Framework for commercial use. , The ... created to “not only elevate the critical role of information technology in modern ...
Breaking Biology Technology:
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
Breaking Biology News(10 mins):